AGBL5 and retinal disorder: Association of AGBL5 with RP in humans was first reported in 2015 and since then evidence for its role in retinal disease has increased and it is now part of the green list of the Retinal Disorders panel (Version 6.0) in Genomics England PanelApp (https://panelapp.genomicsengland.co.uk/panels/307/ accessed in August 2024), and is used in genetic screening for retinal disorders in the UK National Health Service NHS.